Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated non-small cell lung cancer (NSCLC) patients.
Cardona
Andrés Felipe
AF
Reguart
Noemí
N
Reveiz
Ludovic
L
D000230:Adenocarcinoma / Q000188:drug therapy / Q000401:mortality; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D019570:Inhalation Exposure; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D012906:Smoke; D015996:Survival Rate; D014934:Wood
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D012906:Smoke; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors